| Literature DB >> 16521870 |
Abstract
BACKGROUND: Patients with severe sickle cell anemia (SCA) have a higher potential for oxidative damage due to chronic redox imbalance in red blood cells that often leads to hemolysis, endothelial injury and recurrent vaso-occlusive episodes. This study evaluated the plasma levels of vitamins A, C and E as indicators of antioxidant status. In addition, serum levels of zinc and copper were also estimated. PATIENTS AND METHODS: Twenty-five adult patients with severe sickle cell anemia (12 males and 13 females aged 29.72+/-12.94 years) and 25 matched controls were studied. Plasma levels of vitamins A, C and E were measured by HPLC technique. Serum zinc and copper levels were measured by atomic absorption spectrometry.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16521870 PMCID: PMC6078551 DOI: 10.5144/0256-4947.2006.17
Source DB: PubMed Journal: Ann Saudi Med ISSN: 0256-4947 Impact factor: 1.526
Characteristics of severe sickle cell patients and normal controls.
| Parameter | Patients (Mean ± SD) | Controls (Mean ± SD) |
|---|---|---|
| N | 25 | 25 |
| - Males | 12 | 17 |
| - Females | 13 | 8 |
| Age (year) | 29.72 ± 12.9 | 29.0 ± 7.56 |
| WBCs (× 109/L) | 10.9 ±4.5 | 5.5 ±1.3 |
| RBCs (× 1012/L) | 3.14 ± 0.7 | 5.0 ± 0.5 |
| Hemoglobin level (g/L) | 88 ± 12 | 145 ± 15 |
| - Hb A (%) | 0 | 96.1 ± 0.6 |
| - Hb S (%) | 83.8 % ± 7.5 | 0 |
| - Hb F (%) | 12.2 % ± 7.4 | 1.4 ± 0.6 |
| - Hb A2 (%) | 3.0 % ± 1.2 | 2.6 ± 0.4 |
| MCV (fL ) | 85.8 ± 11.7 | 86.3 ± 4.1 |
| MCH (pg) | 28.4 ± 4.5 | 29.8 ±1.5 |
| Platelets (× 109/L) | 364 ± 153 | 239 ± 68.2 |
| Reticulocytes (%) | 6.2 ± 2.6 | 1.1 ± 0.5 |
| Bilirubin (μmol/L) | 50.8 ± 29 | 11.4 ± 2.8 |
| Painful episodes/year | 6.0 ± 4 | - |
| Infections/year | 4.2 ± 2.9 | 1.2 ± 0.4 |
| Acute chest syndrome/year | 3 ± 2 | - |
Figure 1Plasma vitamin A and E concentrations in sickle cell disease patients vs. controls.
Figure 2Plasma vitamin C concentrations in sickle cell disease patients vs. controls.
Figure 3Serum zinc and copper concentrations in sickle cell disease patients vs. controls.